Image of Psychopharmacology: Essential Information for Mental Health Profession
DVD

Psychopharmacology: Essential Information for Mental Health Professionals



Dr. Kenneth Carter, a board-certified clinical psychologist with a Master’s degree in clinical psychopharmacology, shares his clinical experience and training to provide detailed information about the range of common medications prescribed for mental health conditions. You will get the latest information on antidepressants, anxiolytics, and common medications for insomnia and Attention-Deficit/Hyperactivity Disorder among others. Through lecture and the examination of multi-disciplinary ethics codes and real case examples, you will take a close look at the ethical decisions that accompany medication use and the non-prescribers role and limits with regards to medication discussions with your patients.

Dr. Carter answers questions from providers in the field and walks through examples of practical clinical discussions that come up every day in practice, including how to discuss scope of practice with your patients in order to optimize their care when working with multiple providers. The goal is for you to finish better prepared to communicate with your clients as well as the prescribers, as Dr. Carter instructs you on how to medications work, their benefits, and the side effects and dangerous reactions associated with them.


Details

Product Details
Average Rating:
   4.8
Faculty:
Kenneth Carter
Duration:
6 Hours 04 Minutes
Copyright:
28 Feb, 2020
Product Code:
RNV054845
Media Type:
DVD - Also available: Digital Seminar
Access:
Never expires.

CPD


Continuing Professional Development Certificates - PESI Australia, in collaboration with PESI in the USA, offers quality online continuing professional development events from the leaders in the field at a standard recognized by professional associations including psychology, social work, occupational therapy, alcohol and drug professionals, counselling and psychotherapy. On completion of the training, a Professional Development Certificate is issued after the individual has answered and submitted a quiz and course evaluation. This online program is worth 6.0 hours CPD.

Handouts

Faculty

Kenneth Carter Related seminars and products: 1

PhD, ABPP


Kenneth Carter, PhD, ABPP, is a board-certified clinical psychologist and professor of Psychology at Oxford College of Emory University in Atlanta, Georgia. Dr. Carter received his MA and PhD in clinical psychology from the University of Michigan in Ann Arbor and a postdoctoral master's degree in clinical psychopharmacology from Fairleigh Dickerson University. Dr. Carter has taught clinical psychopharmacology classes at Emory University since 2005 and has presented highly rated Psychopharmacology workshops to clinicians throughout the United States since 2010. 

Dr. Carter has served as a senior assistant research scientist in the Epidemic Intelligence Service of the Centers for Disease Control and Prevention. He has been a psychotherapist and researcher for more than 20 years, during which time he has garnered awards from the National Institutes of Health, the National Heart, Lung and Blood Institute, and the University of Michigan.  Dr. Carter has presented at numerous conferences and written several books and articles on introductory psychology, neuropsychology, and psychopharmacology. 

Speaker Disclosures:

Financial: Dr. Kenneth Carter is a professor at Oxford College of Emory University. He receives a speaking honorarium from PESI, Inc.

Non-financial: Dr. Kenneth Carter has no relevant non-financial relationship to disclose.


Additional Info

Program Information

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Discuss the proper role of mental health professionals who treat clients receiving both psychotherapeutic medications and psychotherapy.
  2. Describe specific ethical issues and resolutions related to communicating with clients and prescribing professionals about psychotropic medications.
  3. Explain the neurotransmitter systems and neuroanatomy underlying the biological basis for mental disorders and pharmacotherapy.
  4. Identify the major classes of drugs used to treat mental disorders and which mental disorders are appropriately treated with each class of drugs.
  5. Describe adverse effects and drug reactions of the commonly prescribed psychotropic medications and when to alert the prescriber about them.
  6. Analyze the role that half-life plays in the efficacy of insomnia medications prescribed for clients and how it may affect behavioural interventions.

Outline

MEDS 101
  • Case study
  • Reasons to be knowledgeable about psychiatric medications
  • Lessons from other disciplines
  • Pharmacy
  • Nursing
  • Ethics guidelines
  • The common questions clients have about their medications
  • Handling differences of opinion between yourself and a prescribing professional
GENERAL OVERVIEW OF THE NERVOUS SYSTEM
  • Organization of the nervous system
  • Structure of the neuron
  • Communication between neurons
  • How medicines interact with the nervous system
DEPRESSION MEDICATIONS
  • Neurobiology
  • SSRIs and SNRIs
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case Study
ANXIETY DISORDER MEDICATIONS
  • DSM-5® anxiety categories
  • Deconstructionist approach taken by prescribers
  • Neurobiology
  • SRRIs and Benzodiazepines
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
BIPOLAR MEDICATIONS
  • Monotherapy
  • Lithium, anticonvulsants, and 2nd generation
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
ADHD MEDICATIONS
  • Neurobiology
  • Methylphenidate and amphetamine
  • Mechanism of action
  • Delivery systems
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
ANTIPSYCHOTIC MEDICATIONS
  • Psychosis symptoms
  • Neurobiology
  • 1st and 2nd generation
  • Antipsychotics
  • Mechanism of action
  • Benefits and adverse reactions
  • Medications in these categories
  • Case study
INSOMNIA MEDICATIONS
  • Causes and treatments for insomnia
  • Medications for insomnia
  • Half-life
  • Benefits and adverse reactions
  • Case study
LIMITATIONS OF THE RESEARCH & POTENTIAL RISKS

Target Audience

  • Counselors
  • Social Workers
  • Psychologists
  • Psychotherapists
  • Case Managers
  • Marriage & Family Therapists
  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Addiction Counselors
  • Pharmacists
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Other Mental Health & Healthcare Professionals

Reviews

5
4
3
2
1

Overall:      4.8

Total Reviews: 67

Comments

Ellie L - RANDOLPH, Massachusetts

"Enjoyed very much and learned a lot!"

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or email info@pesi.com.au.

Please wait ...

Back to Top